Quadrant Technologies Limited

Meritage Pharma, Inc.

Viropharma Biologics LLC

Cynthia Licalsi

Keith Johnson

Malcolm Hill

Elaine Phillips

Gary H Ward

Bernard Greenspan

Clyde Witham

Hemant Deshmukh

Provided herein are methods for treating, preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those involving the esophagus. Also provided herein are pharmaceutical compositions useful for the methods of the present invention.

Corticosteroid compositions

In a method for creating an immune response, a vaccine is prepared in the form of a dry powder. The powder particles have an aerodynamic particle size range from 1-100 microns. A dose of powder is loaded into a dry powder inhaler. The dose is inhaled with an inspiratory flow rate of less than 60 liters per minute. A mucosal immune response is created via particles of the vaccine material depositing on the upper respiratory tract. A systemic immune response is created via particles of the vaccine material depositing into the deep lung. The vaccine material is size reduced by e.g., jet milling, into the desired range, yet vaccine potency is retained.

Inhaled vaccines

Growing community of inventors

San Diego, CA, United States of America

Cynthia Licalsi